acetylsalicylic acid, combinations with psycholeptics

North America

Canada (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
FIORINAL (50MG+40MG+330MG) caps
Schedule G (CDSA IV)
oral
N02BA71
TEVA-TECNAL (50MG+40MG+330MG) caps
Schedule G (CDSA IV)
oral
N02BA71
TEVA-TECNAL (50MG+40MG+330MG) tabs
Schedule G (CDSA IV)
oral
N02BA71
TRIANAL TABLET (50MG+40MG+330MG) tabs
Schedule G (CDSA IV)
oral
N02BA71
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
FIORINAL (50MG+40MG+330MG) caps
00226327
TEVA-TECNAL (50MG+40MG+330MG) caps
00608238
TEVA-TECNAL (50MG+40MG+330MG) tabs
00608211
TRIANAL TABLET (50MG+40MG+330MG) tabs
01971409
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (27)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
AXOTAL 650MG;50MG tabs
N
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG caps
N
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG caps
N
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
N
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
N
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
N
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
N
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
N
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
N
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
N
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
Y
Rx
oral
N02BA71
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
N
oral
N02BA71
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 325MG;5 caps
Y
Rx
oral
N02BA71
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 325MG;5 caps
Y
Rx
oral
N02BA71
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 325MG;5 caps
Y
Rx
oral
N02BA71
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 325MG;5 caps
N
oral
N02BA71
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 325MG;5 caps
N
oral
N02BA71
EQUAGESIC 325MG;200MG tabs
N
oral
N02BA71
FIORINAL tabs
N
oral
N02BA71
FIORINAL 325MG;50MG;40MG caps
Y
Rx
oral
N02BA71
FIORINAL W/CODEINE 325MG;50MG;40MG;30MG caps
Y
Rx
oral
N02BA71
LANORINAL 325MG;50MG;40MG caps
Y
Rx
oral
N02BA71
LANORINAL 325MG;50MG;40MG tabs
N
oral
N02BA71
MEPRO-ASPIRIN 325MG;200MG tabs
N
oral
N02BA71
MEPROBAMATE AND ASPIRIN 325MG;200MG tabs
N
oral
N02BA71
MICRAININ 325MG;200MG tabs
N
oral
N02BA71
Q-GESIC 325MG;200MG tabs
N
oral
N02BA71
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
AXOTAL 650MG;50MG tabs
88305/1
ANDA
13-10-1983
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG caps
78149/1
ANDA
13-06-2007
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG caps
86231/2
ANDA
12-02-1985
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
86710/2
ANDA
23-08-1983
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
86398/2
ANDA
06-04-1984
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
89448/1
ANDA
01-12-1986
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
86162/2
ANDA
16-02-1984
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
85441/2
ANDA
31-10-1984
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
87048/2
ANDA
09-12-1983
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
88972/1
ANDA
18-06-1985
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
204195/1
ANDA
22-09-2016
BUTALBITAL, ASPIRIN AND CAFFEINE 325MG;50MG;40MG tabs
86237/2
ANDA
23-03-1984
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 325MG;5 caps
74951/1
ANDA
31-08-1998
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 325MG;5 caps
75231/1
ANDA
30-11-2001
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 325MG;5 caps
203335/1
ANDA
30-10-2015
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 325MG;5 caps
75351/1
ANDA
05-03-1999
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 325MG;5 caps
74359/1
ANDA
31-08-1995
EQUAGESIC 325MG;200MG tabs
11702/3
NDA
29-12-1983
FIORINAL tabs
17534/3
NDA
16-04-1986
FIORINAL 325MG;50MG;40MG caps
17534/5
NDA
16-04-1986
FIORINAL W/CODEINE 325MG;50MG;40MG;30MG caps
19429/3
NDA
26-10-1990
LANORINAL 325MG;50MG;40MG caps
86996/2
ANDA
11-10-1985
LANORINAL 325MG;50MG;40MG tabs
86986/2
ANDA
18-10-1985
MEPRO-ASPIRIN 325MG;200MG tabs
89127/1
ANDA
02-03-1987
MEPROBAMATE AND ASPIRIN 325MG;200MG tabs
89126/1
ANDA
19-08-1986
MICRAININ 325MG;200MG tabs
84978/1
ANDA
01-01-1982
Q-GESIC 325MG;200MG tabs
88740/1
ANDA
01-06-1984
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (0)
No result.
Belgium (0)
No result.
Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (0)
No result.
Lithuania (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ASKOFENAS L 200 MG/200 MG/36,61 MG tabs
N10 blister
N20 blister
N30 blister
N50 blister
OTC
OTC
OTC
OTC
oral
N02BA71
NEOASKOFENAS 200 MG/200 MG/40 MG tabs
N100 blister
N20 blister
N50 blister
OTC/Rx
OTC/Rx
OTC/Rx
oral
N02BA71
NEOCITRAMONAS 240 MG/200 MG/30 MG tabs
N100 blister
N20 blister
N50 blister
OTC/Rx
OTC/Rx
OTC/Rx
oral
N02BA71
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ASKOFENAS L 200 MG/200 MG/36,61 MG tabs
N10 blister
N20 blister
N30 blister
N50 blister
LT/1/2000/1776/001
LT/1/2000/1776/002
LT/1/2000/1776/003
LT/1/2000/1776/004
NP
NP
NP
NP
04-07-2000
04-07-2000
04-07-2000
04-07-2000
NEOASKOFENAS 200 MG/200 MG/40 MG tabs
N100 blister
N20 blister
N50 blister
LT/1/2000/1646/003
LT/1/2000/1646/001
LT/1/2000/1646/002
NP
NP
NP
29-12-2000
29-12-2000
29-12-2000
NEOCITRAMONAS 240 MG/200 MG/30 MG tabs
N100 blister
N20 blister
N50 blister
LT/1/95/1647/003
LT/1/95/1647/001
LT/1/95/1647/002
NP
NP
NP
05-04-1995
05-04-1995
05-04-1995
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Malta (0)
No result.
Netherlands (0)
No result.
Norway (0)
No result.
Poland (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ETOPIRYNA TABLETKI OD BóLU GłOWY 300 MG + 100 MG + 50 MG tabs
10 tabs (1 x 10)
10 tabs (1 x 10)
2 tabs
30 tabs
50 tabs
6 tabs (1 x 6)
6 tabs (1 x 6)
-
-
-
-
-
-
-
OTC
OTC
OTC
OTC
OTC
OTC
OTC
-
N02BA71
POLOPIRYNA MAX HOT (500 MG + 300 MG + 50 MG)/SASZ. powd for oral sol
14 sachet
8 sachet
-
-
OTC
OTC
-
N02BA71
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ETOPIRYNA TABLETKI OD BóLU GłOWY 300 MG + 100 MG + 50 MG tabs
10 tabs (1 x 10)
10 tabs (1 x 10)
2 tabs
30 tabs
50 tabs
6 tabs (1 x 6)
6 tabs (1 x 6)
01899
01899
01899
01899
01899
01899
01899
NP
NP
NP
NP
NP
NP
NP
POLOPIRYNA MAX HOT (500 MG + 300 MG + 50 MG)/SASZ. powd for oral sol
14 sachet
8 sachet
20617
20617
NP
NP
Product
Pack
SPC
PIL
Company
ETOPIRYNA TABLETKI OD BóLU GłOWY 300 MG + 100 MG + 50 MG tabs
10 tabs (1 x 10)
10 tabs (1 x 10)
2 tabs
30 tabs
50 tabs
6 tabs (1 x 6)
6 tabs (1 x 6)
POLOPIRYNA MAX HOT (500 MG + 300 MG + 50 MG)/SASZ. powd for oral sol
14 sachet
8 sachet
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (0)
No result.
Slovenia (0)
No result.
Spain (0)
No result.
Sweden (0)
No result.
Switzerland (0)
No result.